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The term "insomnia" is often used imprecisely in both the medical literature and lay press. It should not be used to refer to sleep symptoms or complaints in a general sense, and it must always be distinguished from sleep deprivation, which has different causes and consequences.
Diagnosis
The diagnosis of chronic insomnia rests on a detailed clinical history. In particular, the history should focus on premorbid sleep characteristics, specific sleep symptoms, chronology of the problem, exacerbating and alleviating factors, and response to previous treatments. The insomnia problem should be viewed from a 24-hour perspective covering the patient's usual sleep and wake periods. This includes consideration of behaviors, cognitions, and environmental factors related to sleep and the sleep environment as well as the regularity of sleep hours from day to day. Other sleep-related symptoms must be assessed, including restless legs, snoring or breathing problems, and abnormal movements or behaviors during sleep. Daytime activities should be reviewed, with particular emphasis on exercise, regularity of work and daytime activities, limitations in these activities, daytime sleepiness, and napping. Finally, interviewing the patient's bed partner may elicit symptoms not evident to the patient.
A thorough medical and psychiatric history is also critical in the evaluation of insomnia, given the frequent occurrence of comorbid conditions. Medical conditions that cause breathing difficulty, pain, or limited mobility are especially important in evaluating insomnia complaints. Virtually any psychiatric disorder can also be associated with insomnia, including mood, anxiety, substance use, and psychotic disorders. A thorough medication and substance history is also essential and should include prescription and over-the-counter medications, substances such as caffeine and alcohol, and drugs of abuse.
Several other tools may aid the diagnostic process. Questionnaires may be useful to quantify sleep, psychiatric, and medical symptoms as well as a predisposition to worry or to have insomnia under stress. A 2-week sleep-wake diary, either in text or graphical form, allows patients to record their actual sleep hours and experiences and can help establish patterns of sleep and day-to-day variability. Actigraphy is an objective means of assessing rest-activity patterns, using a motion-sensitive device worn on the nondominant wrist. Similar to the sleep diary, actigraphy can be useful for examining temporal patterns, variability, and responses to treatment. Polysomnography (PSG), or a sleep study, is the gold standard for quantifying sleep and sleep disturbances. However, PSG is not routinely recommended for the Disclosure: Dr. Buysse is a consultant for Actelion, Cephalon, Eli Lilly, Merck, Neurocrine, Pfizer, Respironics, Sanofi-Synthelabo, Servier, Sepracor, and Takeda evaluation of chronic insomnia 2 because, in most cases, PSG simply confirms the patient's subjective report without indicating a cause for awakenings. However, PSG may be useful in specific clinical situations, such as the suspicion of sleep apnea, periodic limb movements, or parasomnias.
Classification
Classifications for insomnia are typically based on symptoms, duration, or presumed etiology. Symptom-based classifications (i.e., sleep onset, sleep maintenance, or mixed type insomnia) are of limited value, since the specific type of sleep complaint often varies within an individual over time, 3 and a majority of patients actually complain of more than one type of sleep disturbance. Duration-based classifications, such as transient (several days), short-term (up to 3 weeks), and long-term insomnia 4 or occasional, repeated brief and continued insomnia, 5 have had limited validation and are of questionable value given the high rate of chronicity and recurrence in insomnia. Transient and short-term insomnias are often related to specific psychosocial or environmental stresses, whereas chronic insomnia is more often related to intrinsic sleep disorders or primary insomnia.
Etiology-based classifications are the most useful for categorizing chronic insomnia. Specific classification systems include the International Classification of Disease (ICD)-9, the ICD-10, 6 the Diagnostic and Statistical Manual-Fourth Edition (DSM-IV), 7 and the International Classification of Sleep Disorders Second Edition (ICSD-2). 8 In general, the ICD has the broadest, least well-described categories; the DSM-IV has somewhat more specific categories; and the ICSD-2 has the most specific, with over 40 disorders that can present with insomnia symptoms. Each of the major classification systems describes three broad categories of etiologically-defined insomnia disorders.
Etiology
The insomnia syndrome is commonly described as being secondary to other conditions, associated with other sleep disorders, or primary when no other etiology can be identified. Secondary insomnia refers to the insomnia syndrome when it is thought to be due to a medical or psychiatric disorder or to the effects or withdrawal from a substance/medication. This is the largest single group of chronic insomnia diagnoses seen in epidemiological studies and clinical samples. 9, 10 In practice, however, it is often very difficult to distinguish whether insomnia is truly caused by these other conditions or whether it is simply comorbid. 11, 12 Insomnia associated with other sleep disorders includes Restless Legs Syndrome, Obstructive or Central Sleep Apnea Syndrome, parasomnias, or other sleep disorders. Primary insomnias are those disorders in which insomnia is the major symptom, with no other disorder as a likely cause. The DSM-IV includes a single category for primary insomnia, whereas the ICSD-2 includes narrower categories of insomnia, such as psychophysiological, idiopathic, and paradoxical insomnias, which have received some support from validation studies.
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Research Gaps and Needs
Despite its prevalence and widespread acceptance as a medical/psychiatric condition, major gaps and needs still exist in the definition and classification of chronic insomnia. These include:
(1) a more precise determination of the cause of insomnia complaints-not all poor sleepers complain of insomnia, and not all insomnia patients have objectively poor sleep, 15 suggesting that sleep disturbance alone is not the sole cause; (2) a better understanding of the natural history of insomnia and its longitudinal association with medical and psychiatric conditions; (3) further validation of specific insomnia subtypes and differential treatment response; and (4) better tools for assessment and diagnosis, including consistent standards for diagnosis and reporting of results; validated assessment tools, including structured diagnostic interviews; and objective indicators of insomnia and its daytime impairments.
